Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Piscitelli

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|October 13, 2000
Preventing dangerous drug interactionsS Piscitelli
Journal of Biomedical Engineering|July 1, 1987
Tentacle regeneration in Hydra: a quantitative methodological approachG Nolfe, P Pierobon, S Piscitelli
HIV Clinical Trials|October 23, 2013
Pharmacokinetics, safety, and monotherapy antiviral activity of GSK1265744, an HIV integrase strand transfer inhibitorW Spreen, S Min, S L Ford, et al.
Antimicrobial Agents and Chemotherapy|September 26, 1997
Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasisT J Walsh, P Whitcomb, S Piscitelli, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemiaR Petraitiene, V Petraitis, A H Groll, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
Compartmental pharmacokinetics and tissue drug distribution of the pradimicin derivative BMS 181184 in rabbitsA H Groll, T Sein, V Petraitis, et al.
Clinical Nephrology|September 10, 1999
A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapyD T Boumpas, I O Tassiulas, T A Fleisher, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Antifungal activity of the pradimicin derivative BMS 181184 in the treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbitsC E Gonzalez, A H Groll, N Giri, et al.
Journal of Clinical Psychopharmacology|December 24, 1998
Gabapentin does not alter single-dose lithium pharmacokineticsM A Frye, T A Kimbrell, R T Dunn, et al.
Journal of Clinical Microbiology|June 2, 2000
Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasisT J Walsh, C E Gonzalez, S Piscitelli, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|October 13, 2000
Preventing dangerous drug interactionsS Piscitelli
Journal of Biomedical Engineering|July 1, 1987
Tentacle regeneration in Hydra: a quantitative methodological approachG Nolfe, P Pierobon, S Piscitelli
HIV Clinical Trials|October 23, 2013
Pharmacokinetics, safety, and monotherapy antiviral activity of GSK1265744, an HIV integrase strand transfer inhibitorW Spreen, S Min, S L Ford, et al.
Antimicrobial Agents and Chemotherapy|September 26, 1997
Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasisT J Walsh, P Whitcomb, S Piscitelli, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemiaR Petraitiene, V Petraitis, A H Groll, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
Compartmental pharmacokinetics and tissue drug distribution of the pradimicin derivative BMS 181184 in rabbitsA H Groll, T Sein, V Petraitis, et al.
Clinical Nephrology|September 10, 1999
A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapyD T Boumpas, I O Tassiulas, T A Fleisher, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Antifungal activity of the pradimicin derivative BMS 181184 in the treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbitsC E Gonzalez, A H Groll, N Giri, et al.
Journal of Clinical Psychopharmacology|December 24, 1998
Gabapentin does not alter single-dose lithium pharmacokineticsM A Frye, T A Kimbrell, R T Dunn, et al.
Journal of Clinical Microbiology|June 2, 2000
Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasisT J Walsh, C E Gonzalez, S Piscitelli, et al.
Pageof 2